Balanced news tone
News Sentiment
JNJ sentiment intelligence
Johnson & Johnson news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
30 relevant articles
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-4.1% over one week, -1.0% over four weeks, trend active, and materially above fair value.
Johnson & Johnson (JNJ) Could Explore Acquisitions Amid Dermatol
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
80/100 classification
One-week reaction
-4.1%
Price reacting lower
Trend fit
Trend active
-1.0% over four weeks
Fair value
34.0%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
11
Neutral
18
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
GuruFocus
Direct company coverage
Johnson & Johnson (JNJ) Could Explore Acquisitions Amid Dermatol
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 11:35
- Source
- GuruFocus
MarketBeat
Direct company coverage
Johnson & Johnson $JNJ Shares Bought by Uhlmann Price Securities LLC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 09:28
- Source
- MarketBeat
Insider Monkey
Direct company coverage
How Johnson & Johnson (JNJ) Is Using U.S. Manufacturing Investment to Strengthen Its Vision Business
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:58
- Source
- Insider Monkey
MarketBeat
Direct company coverage
Cornerstone Planning LLC Buys New Shares in Johnson & Johnson $JNJ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:42
- Source
- MarketBeat
Seeking Alpha
Direct company coverage
Johnson & Johnson: An Excellent Portfolio Option To Barbell AI, Initiate Buy Rating
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 22 Jun 2026 07:36
- Source
- Seeking Alpha
MarketBeat
Direct company coverage
BI Asset Management Fondsmaeglerselskab A S Sells 56,423 Shares of Johnson & Johnson $JNJ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:08
- Source
- MarketBeat
simplywall.st
Direct company coverage
Johnson & Johnson (JNJ) Stock Could Be 7.3% Undervalued Based On Its Pharma And MedTech Focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 02:32
- Source
- simplywall.st
Market source
Direct company coverage
Johnson & Johnson (JNJ) Stock Draws Fresh Price Target Split On Pipeline Promise And Policy Risk
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 20 Jun 2026 02:06
- Source
- Market source
simplywall.st
Direct company coverage
Johnson & Johnson (JNJ) Stock After Strong One-Year Run Is There Still Value Here
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Jun 2026 18:44
- Source
- simplywall.st
Trefis
Direct company coverage
The Number That Could Test Johnson & Johnson Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 17:06
- Source
- Trefis
Market source
Direct company coverage
Johnson & Johnson (JNJ) Stock After 55% One-Year Surge Is There Still Value Here
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jun 2026 22:21
- Source
- Market source
IndexBox
Direct company coverage
Johnson & Johnson Dividend Stock Analysis: 64 Years of Increases and Current Valuation - News and Statistics
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 06 Jun 2026 15:10
- Source
- IndexBox
Market source
Direct company coverage
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Market source
AD HOC NEWS
Direct company coverage
Johnson & Johnson stock (US4781601046): steady trading ahead of next earnings focus
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2026 12:53
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Johnson & Johnson stock (US4781601046): shares steady ahead of next earnings after solid Q1 2026 upd
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Johnson & Johnson stock (US4781601046): cancer trial data spotlight oncology pipeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Johnson & Johnson stock (US4781601046): oncology trial update and analyst focus at the start of June
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 01 Jun 2026 07:00
- Source
- AD HOC NEWS
Insider Monkey
Direct company coverage
Is Johnson & Johnson (JNJ) One of the Best Dividend Paying Stocks to Buy Right Now?
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 31 May 2026 07:00
- Source
- Insider Monkey
Market source
Direct company coverage
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Market source
DirectorsTalk Interviews
Direct company coverage
Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant With 7.95% Potential Upside
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- DirectorsTalk Interviews
24/7 Wall St.
Direct company coverage
This Will Be Johnson and Johnson’s Stock Price in 2027
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- 24/7 Wall St.
24/7 Wall St.
Direct company coverage
Russell 1000 Dividend ETF Hits $125 as Johnson & Johnson Leads The Safety Test
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 13 May 2026 07:00
- Source
- 24/7 Wall St.
Trefis
Direct company coverage
Johnson & Johnson Stock On A Winning Streak: Time To Get In Or Book Profits?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- Trefis
Barchart.com
Direct company coverage
Are Wall Street Analysts Bullish on Johnson & Johnson Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Barchart.com
MLQ.ai
Direct company coverage
Johnson & Johnson Posts Strong Q1 2026, Raises Full-Year Guidance
- Tone
- Positive 82/100
- Event
- Guidance
- Published
- 14 Apr 2026 07:00
- Source
- MLQ.ai
Barron's
Direct company coverage
Buy Johnson & Johnson Stock Ahead of Earnings, Analyst Says. The Run-Up Isn’t Over.
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 08 Apr 2026 07:00
- Source
- Barron's
JUVE Patent
Direct company coverage
BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Feb 2026 08:00
- Source
- JUVE Patent
Reuters
Direct company coverage
Johnson & Johnson lifts 2025 forecast, halves tariff cost outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 16 Jul 2025 07:00
- Source
- Reuters
Forbes
Direct company coverage
Is Johnson & Johnson Stock A Better Pick Over Merck?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2024 07:00
- Source
- Forbes
markets.businessinsider.com
Direct company coverage
Johnson & Johnson surges 9% after saying its coronavirus vaccine will begin human testing by September
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Mar 2020 07:00
- Source
- markets.businessinsider.com